$11.95
2.05% yesterday
Nasdaq, May 20, 10:00 pm CET
ISIN
US68401U2042
Symbol
OPRX

OptimizeRx Corporation Stock price

$11.95
+3.57 42.60% 1M
+7.53 170.36% 6M
+7.09 145.88% YTD
-1.13 8.64% 1Y
-14.17 54.25% 3Y
+0.82 7.37% 5Y
+8.89 290.52% 10Y
Nasdaq, Closing price Tue, May 20 2025
-0.25 2.05%
ISIN
US68401U2042
Symbol
OPRX
Industry

Key metrics

Market capitalization $221.02m
Enterprise Value $237.25m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 34.99
EV/Sales (TTM) EV/Sales 2.51
P/S ratio (TTM) P/S ratio 2.34
P/B ratio (TTM) P/B ratio 1.90
Revenue growth (TTM) Revenue growth 20.66%
Revenue (TTM) Revenue $94.37m
EBIT (operating result TTM) EBIT $-3.30m
Free Cash Flow (TTM) Free Cash Flow $6.78m
Cash position $16.57m
EPS (TTM) EPS $-0.84
P/E forward negative
P/S forward 2.14
EV/Sales forward 2.30
Short interest 10.50%
Show more

Is OptimizeRx Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

OptimizeRx Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a OptimizeRx Corporation forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a OptimizeRx Corporation forecast:

Buy
86%
Hold
14%

Financial data from OptimizeRx Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
94 94
21% 21%
100%
- Direct Costs 38 38
14% 14%
40%
56 56
26% 26%
60%
- Selling and Administrative Expenses 55 55
4% 4%
58%
- Research and Development Expense - -
-
-
1.06 1.06
113% 113%
1%
- Depreciation and Amortization 4.36 4.36
45% 45%
5%
EBIT (Operating Income) EBIT -3.30 -3.30
70% 70%
-3%
Net Profit -15 -15
15% 15%
-16%

In millions USD.

Don't miss a Thing! We will send you all news about OptimizeRx Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

OptimizeRx Corporation Stock News

Neutral
GlobeNewsWire
5 days ago
WALTHAM, Mass., May 16, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced that management will participate in the following upcoming investor conferences:
Neutral
Seeking Alpha
8 days ago
OptimizeRx Corporation (NASDAQ:OPRX ) Q1 2025 Earnings Conference Call May 12, 2025 4:30 PM ET Company Participants Steve Silvestro - Chief Executive Officer Edward Stelmakh - Chief Financial Officer Andrew D'Silva - Senior Vice President, Corporate Finance Conference Call Participants Ryan Daniels - William Blair David Grossman - Stifel Richard Baldry - ROTH Capital Maxwell Michaelis - Lake St...
Neutral
GlobeNewsWire
8 days ago
WALTHAM, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today reported results for the three months ended March 31, 2025. Quarterly comparisons are to the same year-ago period.
More OptimizeRx Corporation News

Company Profile

OptimizeRx Corp. engages in the provision of digital health messaging via electronic health records, which serves as a direct channel for pharmaceutical companies to communicate with healthcare providers. It offers EHR workflow solutions which include financial messaging, patient education, and brand messaging; and brand support. The company was founded by David A. Harrell on November 8, 1985 and is headquartered in Rochester, MI.

Head office United States
CEO Stephen Silvestro
Employees 129
Founded 1985
Website www.optimizerx.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today